8 Essential Rules for Investing in Your 20s

Know what you are buying. Investors should understand the long-term opportunities of their holdings as well as the risks.

First Business Financial Services (FBIZ) Q3 Earnings and Revenues Top Estimates

First Business Financial Services (FBIZ) delivered earnings and revenue surprises of +15.39% and +1.52%, respectively, for ...

Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Agios Pharmaceuticals (AGIO) possesses the right combination of the two key ingredients for a likely earnings beat in its ...
Wall Street Journal

CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion

CD&R and McKesson MCK-1.14%decrease; down pointing triangle will acquire Option Care Health, which offers infusion therapy and services to patients at home, for about $5.8 billion including debt.
Reuters

McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal

McKesson to invest about $1.4 billion for 49% stake in Option Care Deal expected to close in first half of 2027 Option Care is the largest independent US infusion therapy provider The per-share offer ...
Barron's

Report of Possible $5 Billion Takeover Bid Sends Option Care Health Stock Surging

Healthcare giant McKesson and a private-equity firm are nearing a deal to acquire Option Care Health, a provider of home and outpatient infusion therapy, the Financial Times reported Monday. Investors ...
Reuters

McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports

Oct 5 (Reuters) - Drug distributor McKesson (MCK.N), opens new tab and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider ‌Option Care Health in a ...